Global Anesthesia Endotracheal Tubes Market to Reach US$ 238.6 Million by 2028, Propelled by Rising Prevalence of Chronic Diseases

According to the latest report by IMARC Group, titled “Anesthesia Endotracheal Tubes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global anesthesia endotracheal tubes market size reached US$ 173.0 Million in 2022. Anesthesia endotracheal tubes (ETTs) refer to soft, flexible, and hollow devices that facilitate respiration in patients during medical procedures. They are inserted through the mouth or nose into the trachea to provide a secure airway for breathing and mechanical ventilation. They are manufactured using lightweight, durable, and non-toxic raw materials, such as silicone, polyvinyl chloride (PVC), polyurethane, and thermoplastic elastomers (TPE). Anesthesia ETTs are widely used during surgery, emergency airway management, respiratory failure, pulmonary edema, critical care, and diagnostic procedures. They are easy-to-use, biocompatible, and highly efficient products that ensure adequate oxygenation, minimize complications, and reduce the risk of aspiration, respiratory infections, and pneumonia.

Anesthesia Endotracheal Tubes Market Trends:

The increasing prevalence of chronic diseases due to genetics, sedentary lifestyles, and unhealthy eating habits is one of the key factors driving the market growth. Anesthesia ETTs are widely used to manage the airway and provide mechanical ventilation during the treatment of cystic fibrosis, sleep apnea, acute respiratory distress syndrome (ARDS), neuromuscular diseases, idiopathic pulmonary fibrosis (IPF), and chronic obstructive pulmonary disease (COPD). Furthermore, the widespread product utilization during various diagnostic procedures, such as bronchoscopy, laryngoscopy, tracheostomy, and pulmonary function testing, to facilitate the examination of lungs, vocal cords, and other structures in the throat, are providing an impetus to the market growth. Additionally, the recent development of ultra-thin anesthesia ETTs that improve patient comfort, prevent airway trauma, minimize the risk of injuries, and increase the efficiency of surgical procedures is positively influencing the market growth. Apart from this, the introduction of antimicrobial coatings that prevent bacterial colonization, reduce the risk of ventilator-associated pneumonia (VAP), and improve patient outcomes is favoring the market growth. Moreover, the increasing number of surgical procedures due to injuries, accidents, trauma, and other medical conditions is propelling the market growth. Other factors, including the rising geriatric population, significant growth in the healthcare industry, and increasing investment in the research and development (R&D) of advanced products, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 238.6 Million by 2028, exhibiting a CAGR of 5.6% during 2023-2028.

Market Summary:

• On the basis of the intubation type, the market has been divided into nasotracheal, orotracheal, and hybrid. Among these, nasotracheal intubation dominates the market.
• Based on the product type, the market has been classified into regular, reinforced/armored, coated, and other tubes. At present, coated tubes holds the largest market share.
• On the basis of end user, the market has been divided into hospitals, ambulatory surgery centers, and others. Among these, hospitals accounted for the largest market share.
• On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa. Among these, North America holds the largest market.
• The competitive landscape of the industry has also been examined, with some of the key players being Becton, Dickinson and Company, Convatec Limited, Fuji Systems Corp., General Electric (GE) Company, Intersurgical Ltd., Medtronic Private Limited, Neurovision Medical Products, SEWOON MEDICAL Co., Ltd., Smiths Group PLC, and Teleflex Incorporated.

Report Scope:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800